histamine and dehydroxymethylepoxyquinomicin

histamine has been researched along with dehydroxymethylepoxyquinomicin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ninomiya, Y; Suzuki, E; Umezawa, K	1
Bevelacqua, Y; Caggia, S; Cardile, V; Coco, M; Frasca, G; Libra, M; Malaponte, G; Mazzarino, MC; Stivala, F; Umezawa, K	1

Other Studies

2 other study(ies) available for histamine and dehydroxymethylepoxyquinomicin

Article	Year
Induction of histidine decarboxylase in macrophages inhibited by the novel NF-kappaB inhibitor (-)-DHMEQ. Biochemical and biophysical research communications, 2009, Feb-06, Volume: 379, Issue:2 Topics: Animals; Benzamides; CCAAT-Enhancer-Binding Protein-beta; Cell Line; Cell Nucleus; Cyclohexanones; Histamine; Histidine Decarboxylase; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Transcription Factor RelA; Transcriptional Activation	2009
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes. Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:7 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Cell Line; Chemokine CCL2; Chemokine CCL5; Cyclohexanones; Histamine; Humans; Hydrocortisone; Inflammation; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-8; Keratinocytes; NF-kappa B	2010

Article

Year

Induction of histidine decarboxylase in macrophages inhibited by the novel NF-kappaB inhibitor (-)-DHMEQ.

Biochemical and biophysical research communications, 2009, Feb-06, Volume: 379, Issue:2

Topics: Animals; Benzamides; CCAAT-Enhancer-Binding Protein-beta; Cell Line; Cell Nucleus; Cyclohexanones; Histamine; Histidine Decarboxylase; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Transcription Factor RelA; Transcriptional Activation

2009

Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes.

Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:7

Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Cell Line; Chemokine CCL2; Chemokine CCL5; Cyclohexanones; Histamine; Humans; Hydrocortisone; Inflammation; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-8; Keratinocytes; NF-kappa B

2010